...Moustafa Elleisy; Desiree Louise Dräger; Heike Zettl; Oliver W. Hakenberg Introduction: To assess differences in referral and pathologic outcomes for uro-oncology cases prior to, during, and after the COVID-19 pandemic, comparing clinical and pathological data from cancer surgeries performed...

... Compliance Cancer Urologic surgery Traditionally, the success of surgical procedures has been measured by clinical and objective outcome parameters such as complication and mortality rates [ 1 ]. These physician -reported outcomes are an important component in the assessment of operative quality...

...Kanuj Malik; Deepak Chandrasekaran; Narayanaswamy Kathiresan; Anand Raja Introduction: Lymph node metastasis is an important prognostic marker in penile cancer. Identification of occult metastasis is by lymphadenectomy based on the histological features of primary tumor; however, this leads...

... was 70% (59–80), by omitting studies that enrolled > 50% of patients at pT stage of 3 or 4, the pooled sensitivity increased to 93% (81–98). Conclusions: Although the studies on SN biopsy of muscle invasive bladder cancer patients resulted in a high detection rate and sensitivity, further validated...

...Eva Maria Lausenmeyer; Klara Braun; Johannes Breyer; Michael Gierth; Stefan Denzinger; Maximilian Burger; Hans-Ullrich Voelker; Wolfgang Otto Background: Cancer/testis antigens (CTA) are expressed in urothelial bladder cancer (UBC). Their therapeutical and prognostic relevance remains unclear. We...

.... Incontinence Prostate Apical Rhabdosphincter Cancer Endoscopic extraperitoneal radical prostatectomy Laparoscopy The life altering functional consequences of undergoing radical prostatectomy (RP) include, but are not limited to, urinary incontinence (UI) and erectile dysfunction (ED). Rates of UI...

... operated patients: 31 (59.6%) with peritoneal dissemination from ovarian cancer, 8 (15.3%) from colorectal cancer, 4 (7.9%) from pseudomyxoma peritonei, 3 (5.7%) from gastric cancer, 2 (3.8%) from peritoneal mesothelioma, 1 (1.9%) from appendiceal cancer, 1 (1.9%) from endometrial cancer, and 1 (1.9%) from...

.... Lymphoma Kidney Cancer Inferior vena cava Case Report Urol Int 1993:51:43-45 Robert C. Eyre M ark S. Huberman Karoly Balogh Divisions of Urology. Oncology, and Pathology, Harvard Medical School, New England Deaconess Hospital, Boston, Mass., USA Non-Hodgkin's Lymphoma of the Kidney with Inferior Vena...

... National Hospital, and Bombay Hospital Institute of Medical Sciences; Department of Nephrology and Medical Oncology, Bombay, India Radical Cystectomy for Invasive Squamous Cell Bladder Cancer in a Renal Transplant Patient Keywords Cystectomy Squamous Cancer Bladder Renal transplant Abstract A rare case...

... surface receptor for EGF and transforming growth factor-Α which is overexpressed by a number of human tumours. This article principally reviews previous investigations of the role of the epidermal growth factor receptor in bladder cancer and examines methods of detection, the correlation between EGFr...

...Warren R. McKay Three ways to treat pain from malignancy include modifying the source of pain, interrupting transmission of pain, or altering the perception of pain. This review will discuss agents or techniques used for cancer pain relief through interrupting transmission and altering...

... Deployment and Protooncogene Expression in Human Diseased Prostate M.E.A. Phillipsa, M.A. Ferrob, P.J.B. Sm ithh, P. Daviesa aTenovus Institute for Cancer Research, University of Wales College of Medicine, Cardiff, and bUro!ogy Department, Bristol Royal Infirmary, Bristol, UK Key Words. Prostate...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Penis Dermatoses Benign tumors Cancer Pseudocancer Precancer...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Human prostate Cancer Therapy...

...U. Stöber The body’s intrinsic defence against cancer depends mainly on cells of the lymphatic and reticulo-endothelial system, recognisable by an infiltration of mononuclear round cells into tumour tissue. In contrast to bladder carcinoma, cellular immune defence reactions to prostate carcinoma...

...A. Feustel; M. Schönfelder; F. Wohlrab Perineal puncture procured material from 10 patients with clinically and microscopically proven prostatic cancer, both before and after intensive female-hormonal therapy and after castration; the tissues were studied histochemically and microscopically. Apart...

... population. We previously reported that CD4 lymphocytopenia is associated with a high incidence of skin cancer in RTR. Here, we investigate whether persistent CD4 T cell lymphopenia is associated with GUT occurrence. Patients and Methods: A total of 433 patients were included in this study. All patients...

...Maciej Salagierski; Marek Salagierski; Anna Salagierska-Barwińska; Marek Sosnowski Metastatic renal cancer has a very poor prognosis and constitutes a challenge to uro-oncologists. We present a patient who in the 10 years following the diagnosis of renal cell carcinoma developed nine consecutive...

...Robert D. Brierly; Tim S. O’Brien Introduction: The aim of this study was to identify patients with advanced urological cancer who may benefit from specialist palliative care and to quantify the number of these patients, characterize their problems and to see if their needs were being met. Methods...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Cancer Metastasis Prostate Urethra Urologia Internationalis Case Report...